PLoS ONE (Jan 2016)

Dextran Nanoparticle Synthesis and Properties.

  • Iga Wasiak,
  • Aleksandra Kulikowska,
  • Magdalena Janczewska,
  • Magdalena Michalak,
  • Iwona A Cymerman,
  • Andrzej Nagalski,
  • Peter Kallinger,
  • Wladyslaw W Szymanski,
  • Tomasz Ciach

DOI
https://doi.org/10.1371/journal.pone.0146237
Journal volume & issue
Vol. 11, no. 1
p. e0146237

Abstract

Read online

Dextran is widely exploited in medical products and as a component of drug-delivering nanoparticles (NPs). Here, we tested whether dextran can serve as the main substrate of NPs and form a stable backbone. We tested dextrans with several molecular masses under several synthesis conditions to optimize NP stability. The analysis of the obtained nanoparticles showed that dextran NPs that were synthesized from 70 kDa dextran with a 5% degree of oxidation of the polysaccharide chain and 50% substitution with dodecylamine formed a NP backbone composed of modified dextran subunits, the mean diameter of which in an aqueous environment was around 100 nm. Dextran NPs could be stored in a dry state and reassembled in water. Moreover, we found that different chemical moieties (e.g., drugs such as doxorubicin) can be attached to the dextran NPs via a pH-dependent bond that allows release of the drug with lowering pH. We conclude that dextran NPs are a promising nano drug carrier.